These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9288174)

  • 1. Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as antagonists of the NMDA receptor-channel complex.
    Grauert M; Bechtel WD; Ensinger HA; Merz H; Carter AJ
    J Med Chem; 1997 Aug; 40(18):2922-30. PubMed ID: 9288174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BIII 277 CL is a potent and specific ion-channel blocker of the NMDA receptor-channel complex.
    Carter AJ; Bechtel WD; Grauert M; Harrison P; Merz H; Stransky W
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1382-9. PubMed ID: 8531106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-methyl-D-aspartate receptor channel block by the enantiomeric 6,7-benzomorphans BIII 277 CL and BIII 281 CL.
    Grauert M; Rho JM; Subramaniam S; Rogawski MA
    J Pharmacol Exp Ther; 1998 May; 285(2):767-76. PubMed ID: 9580625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
    Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
    J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of indole-2-carboxylate derivatives as antagonists of N-methyl-D-aspartate receptor activity at the associated glycine recognition site.
    Hood WF; Gray NM; Dappen MS; Watson GB; Compton RP; Cordi AA; Lanthorn TH; Monahan JB
    J Pharmacol Exp Ther; 1992 Aug; 262(2):654-60. PubMed ID: 1386886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Many agents that antagonize the NMDA receptor-channel complex in vivo also cause disturbances of motor coordination.
    Carter AJ
    J Pharmacol Exp Ther; 1994 May; 269(2):573-80. PubMed ID: 7514220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity.
    Carling RW; Leeson PD; Moore KW; Moyes CR; Duncton M; Hudson ML; Baker R; Foster AC; Grimwood S; Kemp JA; Marshall GR; Tricklebank MD; Saywell KL
    J Med Chem; 1997 Feb; 40(5):754-65. PubMed ID: 9057862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of 1,2,3,4-tetrahydroquinoline-2,3,4-trione 3-oximes: novel and highly potent antagonists for NMDA receptor glycine site.
    Cai SX; Zhou ZL; Huang JC; Whittemore ER; Egbuwoku ZO; Lü Y; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1996 Aug; 39(17):3248-55. PubMed ID: 8765507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as use-dependent sodium channel blockers for the treatment of stroke.
    Grauert M; Bechtel WD; Weiser T; Stransky W; Nar H; Carter AJ
    J Med Chem; 2002 Aug; 45(17):3755-64. PubMed ID: 12166948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of pentacycloundecylamines at the N-methyl-d-aspartate receptor.
    Geldenhuys WJ; Malan SF; Bloomquist JR; Van der Schyf CJ
    Bioorg Med Chem; 2007 Feb; 15(3):1525-32. PubMed ID: 17157509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyamines and the NMDA receptor: modifying intrinsic activities with aromatic substituents.
    Berger ML; Bitar AY; Waitner MJ; Rebernik P; O'Sullivan MC
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2837-41. PubMed ID: 16563762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonopioid motor effects of dynorphin A and related peptides: structure dependence and role of the N-methyl-D-aspartate receptor.
    Shukla VK; Prasad JA; Lemaire S
    J Pharmacol Exp Ther; 1997 Nov; 283(2):604-10. PubMed ID: 9353375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New benzomorphan derivatives of MPCB as MOP and KOP receptor ligands.
    Pasquinucci L; Iadanza M; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Parenti C; De Luca L; Ronsisvalle G
    Pharmazie; 2007 Nov; 62(11):813-24. PubMed ID: 18065096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc and ifenprodil allosterically inhibit two separate polyamine-sensitive sites at N-methyl-D-aspartate receptor complex.
    Berger ML; Rebernik P
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1584-91. PubMed ID: 10336556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lead inhibits the rat N-methyl-d-aspartate receptor channel by binding to a site distinct from the zinc allosteric site.
    Lasley SM; Gilbert ME
    Toxicol Appl Pharmacol; 1999 Sep; 159(3):224-33. PubMed ID: 10486309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists.
    Balsamini C; Bedini A; Diamantini G; Spadoni G; Tontini A; Tarzia G; Di Fabio R; Feriani A; Reggiani A; Tedesco G; Valigi R
    J Med Chem; 1998 Mar; 41(6):808-20. PubMed ID: 9526557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacology of 8-amino-3-[(tetrahydro-2-furanyl)methyl] benzomorphan.
    Zhou Q; Duan WH; Cohen DJ; Bidlack JM; Wentland MP
    Yao Xue Xue Bao; 2003 Oct; 38(10):748-53. PubMed ID: 14730897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endobain E, a brain endogenous factor, is present and modulates NMDA receptor in ischemic conditions.
    Reinés A; Zárate S; Carmona C; Negri G; Peña C; Rodríguez de Lores Arnaiz G
    Life Sci; 2005 Dec; 78(3):245-52. PubMed ID: 16107263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure/NMDA receptor affinity relationships of 1-substituted tetrahydro-3-benzazepines.
    Krull O; Wünsch B
    Bioorg Med Chem; 2004 Mar; 12(6):1439-51. PubMed ID: 15018917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.